Published on Aug 16, 2016
Richard D. Schulick, MD, MBA, FACS, Professor and Chair of Surgery at the University of Colorado Anschutz Medical Campus discusses the recent surgical advances in Pancreatic Cancer treatment and the borderline resectable patient.
His discussion includes a historical perspective, review of how hospital volume impacts the management of pancreas cancer, understanding molecular events and impaired pathways that lead to the disease, early detection, more effective systemic therapies and multidisciplinary care of patients.
View more content at – http://url.bcst.md/5ek7
Category
Science & Technology
License
Standard YouTube License
Recent Advances and the Borderline Resectable Patient –Pancreatic Cancer
